Consistent with this notion, we observed strong immunoreactivity for HMGB1 in inflammatory cells, although other cell types (such as endothelial or smooth muscle cells) could also release HMGB1 and thus contribute to increased circulatory levels in patients with IPAH and COPD+PH. Here, HMGB1 is linked to idiopathic pulmonary arterial hypertension.